Prevalence and timing of prenatal ultrasound findings in cytomegalovirus‐infected pregnancies
Acta Obstetricia et Gynecologica Scandinavica · 2025
DOI: 10.1111/aogs.15018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2025. Verfasst von Emma Van den Eede und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Development and Regeneration, Biomedical Sciences KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Ultrasonography, Prenatal, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Introduction
To investigate the prevalence and timing of prenatal neurosonographic abnormalities after primary cytomegalovirus seroconversion by the first trimester of pregnancy. The additional value of magnetic resonance imaging (MRI) and the correlation between cytomegalovirus viral load in amniotic fluid and adverse neonatal outcomes were evaluated. Material and Methods A retrospective study between 2006 and 2022 examined data from 440 women with amniocentesis for periconceptional and first‐trimester cytomegalovirus seroconversion. Cases with positive amniocentesis and subsequent follow‐up were included. Prenatal neurosonography, MRI, and clinical outcomes were analyzed.
Results
Out of 190 women included, 37% ( n = 70) presented with a normal neurosonography. Patients exhibiting abnormal neurosonography findings showed higher viral loads in amniotic fluid compared to those with a normal neurosonography ( p = 0.002). In 26% ( n = 49) the first abnormal ultrasound sign was already picked up at amniocentesis, and the most common ones were echogenic bowels (49%) and periventricular echogenicity (43%). With increasing gestational age, the likelihood of a new abnormal neurosonography finding decreases. MRI discovered additional abnormalities in 14% ( n = 10).
Conclusions
The results highlight the importance of combining diagnostic modalities, from amniocentesis to biweekly ultrasound monitoring and subsequent MRI evaluation, to capture the chronological progression and subsequent outcome of congenital cytomegalovirus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Development and Regeneration, Biomedical Sciences KU Leuven, Leuven, Belgium.
- Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium.
- Department of Obstetrics and Gynecology, University Hospital Antwerp, Antwerp, Belgium.
- Department of Obstetrics and Gynecology, AZ Groeninge, Kortrijk, Belgium.
- Department of Laboratory Medicine, UZ Leuven, Leuven, Belgium.
- Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
ORCID-Profile: Emma Van den Eede, Bart De Keersmaecker, Lennart Van der Veeken, Michael Aertsen, Luc De Catte
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Van den Eede, E., De Keersmaecker, B., Lagrou, K., Van der Veeken, L., Vanwinkel, S., Vangoitsenhoven, M., Aertsen, M., & De Catte, L. (2025). Prevalence and timing of prenatal ultrasound findings in cytomegalovirus‐infected pregnancies. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.15018
Vancouver
Van den Eede E, De Keersmaecker B, Lagrou K, Van der Veeken L, Vanwinkel S, Vangoitsenhoven M, et al. Prevalence and timing of prenatal ultrasound findings in cytomegalovirus‐infected pregnancies. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.15018
BibTeX
@article{VandenEede2025,
author = {Van den Eede, Emma and De Keersmaecker, Bart and Lagrou, Katrien and Van der Veeken, Lennart and Vanwinkel, Sanne and Vangoitsenhoven, Maja and Aertsen, Michael and De Catte, Luc},
title = {Prevalence and timing of prenatal ultrasound findings in cytomegalovirus‐infected pregnancies},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2025},
doi = {10.1111/aogs.15018}
}
EUVIMED